A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE

Dendritic cell-cytokine-induced killer (DC-CIK) cell therapy has been experimentally implemented for enhancing anti-tumoral immunity in patients with hepatocellular carcinoma (HCC) undergoing postoperative transcatheter arterial chemoembolization (POTACE). We performed a retrospective study to evalu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer biology & therapy 2018-06, Vol.19 (6), p.475-483
Hauptverfasser:	Zhang, Jian, Li, Huizhong, Gao, Dazhi, Zhang, Baofu, Zheng, Maojin, Lun, Mingyin, Wei, Mengxue, Duan, Rui, Guo, Maomao, Hua, Jiajun, Liu, Qian, Bai, Jin, Liu, Hui, Zheng, Junnian, Yao, Hong
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!